Aethlon Medical, Inc. (NASDAQ:AEMD) Is Worth Evaluating At $2.64

Retrieved on: 2021-01-23 19:00:04

Tags for this article:

Financial markets

Finance

Initial public offering

Short

Aethlon Medical Inc.

Click the tags to see associated articles and topics

Aethlon Medical, Inc. (NASDAQ:AEMD) Is Worth Evaluating At $2.64. View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The) is the largest shareholder of the company, while 21 institutions own stock in it. As of Sep 29, 2020, the company held over ...

Article found on: marketingsentinel.com

View Original Article